TCL Archive In Brief: Data Availability From Cancer Survey Presents Problems – Who Gets It first, Confidentiality August 30, 1974
TCL Archive In Brief: Grand Jury To Consider Charges Against N.M. Community Based Cancer Program Staff Members January 4, 1980
TCL Archive In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List December 2, 1983
TCL Archive Three Institutes To Test BioMicro’s Microarray Product. GlycoDesign Allowed Patent For Cancer Drug GD0039. March 1, 2002
TCL Archive Opening Shots Fired In 10 Year Defense of Cancer Program, Launching Of Effort To Continue, Expand It September 19, 1980
